Insider trade

UiPath (PATH)CEO sold ~$676K

Daniel Dines, CEO at UiPath, sold ~$676K of UiPath shares.

~$676K
Approx. value · 45K sh @ $15.02
28M
Holds after · shares reported
Traded
Jan 22, 2026
Filed
Jan 27, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 9, 2025InsiderCEO sold ~$861K of PATH shares in the open market
  2. Dec 10, 2025InsiderCEO sold ~$837K of PATH shares in the open market
  3. Dec 11, 2025InsiderCEO sold ~$835K of PATH shares in the open market
  4. Dec 12, 2025InsiderCEO sold ~$806K of PATH shares in the open market
  5. Dec 15, 2025InsiderCEO sold ~$778K of PATH shares in the open market
  6. Dec 16, 2025InsiderCEO sold ~$732K of PATH shares in the open market
  7. Dec 17, 2025InsiderCEO sold ~$725K of PATH shares in the open market
  8. Dec 22, 2025InsiderCEO sold ~$742K of PATH shares in the open market
  9. Dec 23, 2025InsiderCEO sold ~$742K of PATH shares in the open market
  10. Dec 24, 2025InsiderCEO sold ~$761K of PATH shares in the open market
  11. Dec 26, 2025InsiderCEO sold ~$761K of PATH shares in the open market
  12. Dec 29, 2025InsiderCEO sold ~$740K of PATH shares in the open market
  13. Dec 30, 2025InsiderCEO sold ~$757K of PATH shares in the open market
  14. Dec 31, 2025InsiderCEO sold ~$745K of PATH shares in the open market
  15. Jan 2, 2026InsiderCEO sold ~$737K of PATH shares in the open market
  16. Jan 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.8M)
  17. Jan 6, 2026InsiderCEO sold ~$720K of PATH shares in the open market
  18. Jan 7, 2026InsiderCEO sold ~$779K of PATH shares in the open market
  19. Jan 8, 2026InsiderCEO sold ~$787K of PATH shares in the open market
  20. Jan 9, 2026InsiderCEO sold ~$773K of PATH shares in the open market
  21. Jan 12, 2026InsiderCEO sold ~$747K of PATH shares in the open market
  22. Jan 13, 2026InsiderCEO sold ~$773K of PATH shares in the open market
  23. Jan 14, 2026InsiderCEO sold ~$706K of PATH shares in the open market
  24. Jan 15, 2026InsiderCEO sold ~$692K of PATH shares in the open market
  25. Jan 22, 2026 · this disclosureInsiderCEO sold ~$676K of PATH shares in the open market

What came next

  1. Jan 23, 2026InsiderCEO sold ~$686K of PATH shares in the open market
  2. Jan 26, 2026InsiderCEO sold ~$676K of PATH shares in the open market
  3. Mar 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  4. Mar 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 24, 2026, the Compensation Committee of the Board of Directors (the “Board”) of UiPath, Inc. (the “Company”) appointed Raghavendra Malpani, the Company’s current Chief Technology Officer, as the Company’s Chief Product and Technology Officer, effective March 25, 2026 (the “Effective Date”).”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for UiPath

For UiPath, OQRO holds 9 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PATH page.

Other recent filings by Daniel Dines, CEO and Chairman

The full history of Daniel Dines, CEO and Chairman is on the profile page.

How this filing works

Other disclosures at UiPath

Everything OQRO holds on this company is on its PATH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data